(Q33972736)

30 July 2017

Characterization of vigabatrin-associated optic atrophy (English)

1 reference

30 July 2017

Characterization of vigabatrin‐associated optic atrophy (English)

1 reference

https://api.crossref.org/works/10.1034/J.1600-0420.2003.00125.X

14 March 2024

1 reference

1 reference

https://api.crossref.org/works/10.1034/J.1600-0420.2003.00125.X

14 March 2024

1

Lars Frisén

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14510793

14 March 2024

author name string

Kristina Malmgren

series ordinal

2

1 reference

30 July 2017

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14510793

14 March 2024

publication date

1 October 2003

1 reference

full work available at URL

30 July 2017

https://onlinelibrary.wiley.com/doi/pdfdirect/10.1034/j.1600-0420.2003.00125.x

file format

Portable Document Format

online access status

open access

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14510793

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1034%2Fj.1600-0420.2003.00125.x

14 March 2024

1 reference

https://api.crossref.org/works/10.1034/J.1600-0420.2003.00125.X

https://onlinelibrary.wiley.com/doi/pdf/10.1034/j.1600-0420.2003.00125.x

14 March 2024

1 reference

https://api.crossref.org/works/10.1034/J.1600-0420.2003.00125.X

14 March 2024

1 reference

30 July 2017

81

1 reference

30 July 2017

5

1 reference

30 July 2017

466-473

1 reference

Symptomatic and asymptomatic visual loss in patients taking vigabatrin.

30 July 2017

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0420.2003.00125.X

Automated perimetry: a report by the American Academy of Ophthalmology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0420.2003.00125.X

Severe persistent visual field constriction associated with vigabatrin

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0420.2003.00125.X

Randomized trial of vigabatrin in patients with infantile spasms

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0420.2003.00125.X

Field-specific visual-evoked potentials: identifying field defects in vigabatrin-treated children

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0420.2003.00125.X

Long term changes in the visual fields of patients with temporal lobe epilepsy using vigabatrin

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0420.2003.00125.X

Vigabatrin-associated retinal cone system dysfunction: electroretinogram and ophthalmologic findings.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0420.2003.00125.X

Atrophy of optic nerve fibres in compression of the chiasm. Degree and distribution of ophthalmoscopic changes

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0420.2003.00125.X

Vigabatrin visual toxicity: evolution and dose dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0420.2003.00125.X

Visual dysfunction in patients receiving vigabatrin: clinical and electrophysiologic findings

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0420.2003.00125.X

Vigabatrin associated visual field loss: a clinical audit to study prevalence, drug history and effects of drug withdrawal

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0420.2003.00125.X

No reversion in vigabatrin-associated visual field defects

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0420.2003.00125.X

Visual field loss associated with vigabatrin: pathological correlations

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0420.2003.00125.X

Vigabatrin-associated visual field defects in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0420.2003.00125.X

Visual field constriction in epilepsy patients treated with vigabatrin and other antiepileptic drugs: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0420.2003.00125.X

Visual field constriction: accumulation of vigabatrin but not tiagabine in the retina.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0420.2003.00125.X

Discriminating between normal and glaucomatous eyes using the Heidelberg Retina Tomograph, GDx Nerve Fiber Analyzer, and Optical Coherence Tomograph

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0420.2003.00125.X

Localization of GABA, glycine, glutamate and tyrosine hydroxylase in the human retina

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0420.2003.00125.X

7 January 2021

Non-linear projection of the retinal image in a wide-angle schematic eye.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0420.2003.00125.X

7 January 2021

The human fetal retinal nerve fiber layer and optic nerve head: a DiI and DiA tracing study

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0420.2003.00125.X

7 January 2021

Photography of the retinal nerve fibre layer: an optimised procedure

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0420.2003.00125.X

7 January 2021

Narrowing of the retinal arterioles in descending optic atrophy. A quantitative clinical study

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0420.2003.00125.X

7 January 2021

Separating the retinal electrophysiologic effects of vigabatrin: treatment versus field loss

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0420.2003.00125.X

7 January 2021

Visual field defects associated with vigabatrin therapy

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0420.2003.00125.X

7 January 2021

Is visual field constriction in epilepsy patients treated with vigabatrin reversible?

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0420.2003.00125.X

7 January 2021

Unsharp masking in fundus photography

series ordinal

12

1 reference

https://api.crossref.org/works/10.1034/J.1600-0420.2003.00125.X

Visual Field Loss Associated with Vigabatrin: Quantification and Relation to Dosage

14 March 2024

series ordinal

16

1 reference

https://api.crossref.org/works/10.1034/J.1600-0420.2003.00125.X

14 March 2024

Identifiers

1 reference

30 July 2017

1 reference